Investment

Osteoarthritis
#Arthritis #Investment #Sanofi

Sanofi backs Lifordi with investment for arthritis trial

Sanofi Ventures has invested in biotechnology company Lifordi Therapeutics, bringing Lifordi’s total financing round up to $112 million.  The funding is set to be used to support an ongoing Phase I study in Rheumatoid Arthritis (RA) by evaluating LFD-200, an ADC delivering a potent glucocorticoid (GC) directly to immune cells. It also provides for… Read More

#Business & Investment #News

#ABPI #ALS #Animal models #Cancer research #Covid-19 #Investment #Life sciences #MHRA #MND #mRNA-based vaccines

DDW Highlights: 18 November 2025

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, groundbreaking research showed the Covid-19 mRNA vaccine could boost cancer response. Elsewhere,… Read More

#Podcasts

#Biotech #Europe #Investment #Start-ups #Venture funds

European biotech venture funds raise over €1.1 billion

Two European biotech venture funds have raised over €1.1 billion in capital in the last week.  Sofinnova Partners announced the close of Sofinnova Capital XI at €650 million, while Medicxi closed its Medicxi V fund at €500 million.  Sofinnova Capital XI attracted strong support from a global base of blue-chip… Read More

#Business & Investment #Editor's Choice #News #Start-up Zone

Brain physiology
#Alzheimer's #Investment #Neurodegenerative disorders

Scripta raises $12 million to find disease-modifying drugs 

UK techbio company Scripta Therapeutics has announced it has raised $12 million to find disease-modifying drugs altering transcription factor activity.  The financing round was led by by Oxford Science Enterprises and Apollo Health Ventures, with AlbionVC, YZR Capital, and Parkwalk Advisors, with support from Oxford University Innovation.  Scripta’s approach combines… Read More

#Business & Investment #News

#ABPI #ALS #Animal models #Cancer research #Covid-19 #Investment #Life sciences #MHRA #MND #mRNA-based vaccines

This week in Drug Discovery (10 – 14 November) 

News round-up for 10 – 14 November by Bruno Quinney, Content Team at DDW.  This week’s top story comes from groundbreaking research showing the Covid-19 mRNA vaccine boosts the immune system’s cancer response. The theme of UK investment dominates other headlines, while a report shows an effective… Read More

#News

India on globe
#Drug development #Drug discovery #India #Investment

Syngene International commits new investment to drug discovery

Syngene International has announced new investment in peptide laboratory and advanced automation to accelerate drug discovery and development in India.  The investments include a dedicated peptide laboratory in Bengaluru and the integration of automation across Drug Metabolism and Pharmacokinetics (DMPK) and Direct-to-Biology (D2B) workflows in Hyderabad. The company hopes the… Read More

#Business & Investment #News

#Investment #Sanofi

Sanofi strengthens investor start-up fund by $625 million

Sanofi Ventures has announced an additional $625 million multiyear capital commitment from Sanofi, increasing its total assets under management to over $1.4 billion.  Sanofi Ventures is the corporate venture capital arm of Sanofi, investing in biotech and artificial intelligence/digital health companies that focus on helping patients, aiming to transform the… Read More

#Business & Investment #News

GBP pound sterling funding
#Enhanced Genomics #Investment

Enhanced Genomics receives new funding worth $19 million

Biotechnology company Enhanced Genomics has received new investment in its Series A programme, the company has announced.  Enhanced Genomics, known for pioneering 3D multi-omics to rapidly identify high-confidence, genetically-validated drug targets for common diseases, has received $19 million (£14 million) from BGF, Parkwalk and Meltwind. The funding will be used… Read More

#Business & Investment #News

#GSK #Investment #Manufacturing

GSK to invest $30 billion in US over next five years

GSK will invest $30 billion (£22 billion) across the US over the next five years in research and development and supply chain infrastructure, the company has announced.  The investment includes a new $1.2 billion (£880 million) investment in advanced manufacturing facilities and AI and advanced digital technologies, delivering new next-generation… Read More

#Business & Investment #News

UK financial markets
#AstraZeneca #Drug development #Investment #UK

AstraZeneca halts £200m research investment in UK 

AstraZeneca has halted its planned £200 ($270) million investment in a research facility in Cambridge, UK, according to reports from Reuters.  The investment, which was anticipated to generate 1,000 new jobs, is currently on hold.  The pharmaceutical company's decision indicates that none of its newly announced funding, initially revealed in… Read More

#Business & Investment #News

Johnson & Johnson head office
#Investment #Johnson & Johnson #Manufacturing #New facility #United States

Johnson & Johnson continues US manufacturing investment

Johnson & Johnson has revealed plans to increase its presence in North Carolina with a dedicated manufacturing facility at FUJIFILM’s new biopharmaceutical manufacturing site in Holly Springs, North Carolina.   The $2 billion commitment to FUJIFILM over the next 10 years will expand the company’s US manufacturing capacity and create approximately… Read More

#Business & Investment #News

UK
#Financing #Investment #Life sciences #Start-ups #UK

Growing investor interest in later-stage UK life science companies

New research into the UK life sciences landscape has revealed a growing trend of investment into more mature companies.   Pioneer Group’s ‘Life Science Start Up Report’ also highlights a persistent regional imbalance, with ‘Golden Triangle’ university spinouts attracting significantly more funding than those elsewhere.  Whilst the number of deals in… Read More

#Business & Investment #News #Start-up Zone

Biogen facility in Cambridge, US
#Biogen #Investment #Manufacturing #United States

Biogen commits $2b to modernise US manufacturing facility

Biogen has announced that it intends to invest an additional $2 billion in its existing manufacturing footprint in North Carolina’s Research Triangle Park (RTP). The announcement comes at the same time as AstraZeneca also revealed plans to invest in its US facilities. Since breaking ground in 1995, Biogen’s manufacturing in… Read More

#Business & Investment #News #Trending News

Pascal Soriot, Chief Executive Officer, AstraZeneca
#AstraZeneca #Investment #Metabolic diseases #New facility #United States

AstraZeneca invests $50b in US, plans new chronic disease centre

AstraZeneca will invest $50 billion in the United States by 2030, following similar announcements by other big pharma companies.   The company says the investment will create tens of thousands of new, highly skilled direct and indirect jobs across the country powering growth and delivering next generation medicines for patients… Read More

#Business & Investment #News